ANUH PHARMA LTD. SHARE PRICE [LIVE]

  
NSE: ANUHPHR
N/A
BSE: 506260
91.30
To view real time prices Login to your account
OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
BSE Click here to view BSE data
Live Chart
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality

Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Not Applicable
Sector
-6.89%
Sensex
9.75%
IndustryPharma
MARKET CAP (Micro Cap Stock)Rs Cr
PE (TTM) 0.00
DIVIDEND YIELD 0.00%
PE Ratio13.59
Price to Book Value2.14
EV to EBIT10.67
EV to EBITDA8.38
EV to Capital Employed2.35
EV to Sales0.86
PEG Ratio0.18
Dividend Yield1.92%
ROCE (Latest)19.31%
ROE (Latest)15.74%
NameSep 22Jun 22
Promoters (Change:-0.00) 70.58%70.58%
FIIs (Change:0.00) 0%0%
Mutual Funds (Change:0.00) 0%0%
Insurance Companies (Change:0.00) 0%0%
Other DIIs (Change:0.00) 0%0%
Non Institution (Change:0.00) 29.42%29.42%

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in ANUH PHARMA LTD.

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

ANUHPHR News

Frequently Asked Questions

What is the Share price of ANUH PHARMA LTD. (ANUHPHR)?

ANUH PHARMA LTD. (ANUHPHR) share price as of November 29, 2022, on BSE is Rs 91.30 (BSE).

Can I buy ANUH PHARMA LTD. (ANUHPHR) shares?

Yes, You can buy ANUH PHARMA LTD. (ANUHPHR) shares by opening a Demat account with Angel One.

How do I buy ANUH PHARMA LTD. (ANUHPHR) from Angel One?

ANUH PHARMA LTD. (ANUHPHR) share can be brought through the following modes:
  1. Direct investment: You can buy ANUH PHARMA LTD. (ANUHPHR) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to ANUH PHARMA LTD. (ANUHPHR) shares.

In which sector do ANUH PHARMA LTD. (ANUHPHR) belong?

ANUH PHARMA LTD. (ANUHPHR) belongs to Pharma.

About ANUHPHR

Today's live share price for ANUH PHARMA LTD. is NSE: N/A, BSE: ₹ 91.30 with a current market capitalization of .

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company offers bulk drugs and chemicals. Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group. Anuh Pharma Ltd was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs. The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries. During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg. During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production. In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption. In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption. In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.

Read more

Enjoy Zero Brokerage on Equity Delivery

Join our 1 Cr+ happy customers